Jim Simons Cytocom, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 12, 2021	SELL	N/A	-98,051 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	N/A	-32,500 Reduced 24.89%	98,051 $536,000
Q1 2021 May 13, 2021	SELL	N/A	-35,100 Reduced 21.19%	130,551 $685,000
Q4 2020 Feb 10, 2021	SELL	N/A	-41,100 Reduced 19.88%	165,651 $571,000
Q3 2020 Nov 13, 2020	SELL	N/A	-66,500 Reduced 24.34%	206,751 $407,000
Q2 2020 Aug 13, 2020	SELL	N/A	-16,100 Reduced 5.56%	273,251 $702,000
Q1 2020 May 14, 2020	SELL	N/A	-21,165 Reduced 6.82%	289,351 $480,000
Q4 2019 Feb 13, 2020	BUY	N/A	3,500 Added 1.14%	310,516 $187,000
Q3 2019 Nov 13, 2019	BUY	N/A	3,700 Added 1.22%	307,016 $310,000
Q2 2019 Aug 12, 2019	BUY	N/A	9,900 Added 3.37%	303,316 $440,000
Q1 2019 May 14, 2019	BUY	N/A	6,100 Added 2.12%	293,416 $493,000
Q4 2018 Feb 13, 2019	BUY	N/A	287,316 New	287,316 $290,000

About Cytocom, Inc.

Ticker CBLI
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,468,900
Market Cap $49.1M

More about CBLI

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.